Delcath to trial Hepzato drug device combo in colorectal cancer
Delcath System has received clearance from the US Food and Drug Administration (FDA) for an investigational new drug (IND) application …
Post
-
-
Medicus Pharma and Swanielle partner to expand BCC drug trial to Asia-Pacific
Canadian life sciences company Medicus Pharma has partnered with Japanese healthcare consultancy Swanielle to expand its Phase II clinical trial …
-
Sudo Biosciences begins trial of drug candidate for neuroinflammatory conditions
US-based biopharmaceutical company Sudo Biosciences has initiated a Phase I trial of SUDO-550, a drug candidate designed to treat neuroinflammatory …
-
Four oral GLP-1R products in Phase III trials as race intensifies
The popularity of GLP-1 receptor (GLP-1R) subcutaneous treatments for obesity has proved the demand for the drugs, but the lack …
-
Novocure seeks approval after pancreatic cancer wearable scores at Phase III
Novocure is seeking regulatory approval in the US, EU, Japan and other key markets after the Phase III PANOVA-3 pancreatic …
-
Novocure seeks approval after pancreatic cancer wearable scores at Phase III
Novocure is seeking regulatory approval in the US, EU, Japan and other key markets after the Phase III PANOVA-3 pancreatic …
-
Sidra Medicine conducts paediatric congenital hyperinsulinism trial
Qatar Foundation member Sidra Medicine has conducted the industry-sponsored ‘sunRIZE’ trial for paediatric congenital hyperinsulinism. The first pharmaceutical trial comes after …
-
Cantargia doses first subject in expanded part of CAN10’s Phase I trial
Sweden-based Cantargia has commenced an expanded segment of the ongoing Phase I trial of its antibody, CAN10, with the first …
-
Minghui reports positive topline data from trial of MH004 for atopic dermatitis
Minghui Pharmaceutical has reported positive topline outcomes from the randomised Phase III trial of its pan-Jak inhibitor, MH004 (tofacitinib etocomil) …
-
‘Pill-on-a-thread’ cancer screening trial commences with first patients
A pivotal investigator-led clinical trial for a new ‘pill-on-a-thread’ innovation for oesophageal cancer screening has welcomed its first patients, Cambridge …
-
Tryptamine Therapeutics completes dosing in obesity trial of TRP-8803
Tryptamine Therapeutics (Tryp) has announced the completion of subject dosing in a Phase Ib clinical trial of its psilocin-based intravenous …
-
Albus demonstrates device’s ability to detect asthma attacks in children
UK-based Albus Health (formerly BreathOx) has shared data revealing that its Albus Home AI-powered monitoring device can detect warning signs …
-
Takeda Canada co-sponsors grant to boost IBD clinical research
Takeda Canada has co-sponsored the Canadian Inflammatory Bowel Disease Research Consortium (CIRC) PIONEER Grant to boost clinical research efforts. The company …
-
New breast cancer combo sees success in New York trial
A new combination therapy designed for some of the most aggressive forms of breast cancer has shown promising results in …
-
Radiopharmaceutical trials face extra complexities due to nuclear red tape
The field of radiopharmaceuticals is growing rapidly, with a real buzz in oncology around emerging therapies. Radiopharmaceuticals are drugs that …
